2008
DOI: 10.1371/journal.pone.0004034
|View full text |Cite
|
Sign up to set email alerts
|

Identification and Characterization of Novel MicroRNAs from Schistosoma japonicum

Abstract: BackgroundSchistosomiasis japonica remains a major public health problem in China. Its pathogen, Schistosoma japonicum has a complex life cycle and a unique repertoire of genes expressed at different life cycle stages. Exploring schistosome gene regulation will yield the best prospects for new drug targets and vaccine candidates. MicroRNAs (miRNAs) are a highly conserved class of noncoding RNA that control many biological processes by sequence-specific inhibition of gene expression. Although a large number of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
118
0
1

Year Published

2010
2010
2014
2014

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 98 publications
(121 citation statements)
references
References 28 publications
(40 reference statements)
2
118
0
1
Order By: Relevance
“…The landmark availability of the complete sequences of the S. japonicum (171) and S. mansoni (18) genomes will provide the necessary ancillary information. As well, new approaches in antigen discovery through the generation of a large schistosome transcriptome database, gene finding, and the explosion in postgenome technologies, including DNA microarray profiling, proteomics, glycomics, immunomics, and the application of RNA interference (RNAi) and novel imaging techniques (2,24,25,41,53,72,73,75,76,85,95,109,126,127,179,189,197,205,219,224,230), provide an unprecedented opportunity to identify a new generation of vaccine target molecules that may induce greater potency than the current candidate schistosome antigens (138).…”
Section: Vaccine Developmentmentioning
confidence: 99%
“…The landmark availability of the complete sequences of the S. japonicum (171) and S. mansoni (18) genomes will provide the necessary ancillary information. As well, new approaches in antigen discovery through the generation of a large schistosome transcriptome database, gene finding, and the explosion in postgenome technologies, including DNA microarray profiling, proteomics, glycomics, immunomics, and the application of RNA interference (RNAi) and novel imaging techniques (2,24,25,41,53,72,73,75,76,85,95,109,126,127,179,189,197,205,219,224,230), provide an unprecedented opportunity to identify a new generation of vaccine target molecules that may induce greater potency than the current candidate schistosome antigens (138).…”
Section: Vaccine Developmentmentioning
confidence: 99%
“…Along with let-7, the miRNA bantam that is extraordinarily highly expressed in cercaria is supposed to be active in developmental processes through regulation of a cellular population size. 59 However, a recent study preferably supports the notion that let-7 has other functions rather than controlling developmental timing. 60 It is clear that these presumptions need to be further experimentally tested.…”
mentioning
confidence: 97%
“…The previously described hammerhead ribozyme RNA (Ferbeyre et al 1998) is the most diverse because it originates from repetitive DNA; tRNAs were found to be the next most diverse ncRNAs encoded in the S. mansoni genome (tRNAscan-SE predicted a total of 713 tRNAs) (Copeland et al 2009). The authors focused on the comparison between tRNA populations in other schistosomes and in a free-living platyhelminth organism (Schmidtea mediterranea); they also confirmed in S. mansoni the first miRNAs described in S. japonicum by Xue et al (Xue et al 2008).…”
Section: Other Non-coding Rnasmentioning
confidence: 82%
“…The first miRNAs characterized in schistosomes were described in 2008 (Xue et al 2008). In that work the authors described 227 cloned microRNAs in S. japonicum.…”
Section: Short Non-coding Rnasmentioning
confidence: 99%